Q Global Advisors’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Q Global Advisors’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-250,000	Closed	-$5K	–	184
2023 Q1	$5K	Hold	250,000	–	–	﹤0.01%	160
2022 Q4	$37K	Hold	250,000	–	–	0.02%	28
2022 Q3	$45K	Buy	+250,000	New	+$36.6K	0.03%	21

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Q Global Advisors's PEARW Position: Q2 2023 in Review

Q Global Advisors sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 250,000 shares — an estimated $5K sold.

Q Global Advisors first reported a position in PEARW in Q3 2022 and held it in 3 quarters. The position peaked at $45K in Q3 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Q Global Advisors reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Q Global Advisors sold 250,000 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $5K.
Q Global Advisors first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2022 and held it in 3 quarters.
Q Global Advisors's Pear Therapeutics, Inc. Warrant position peaked at $45K in Q3 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Q Global Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.